Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects

By Wemer Johan   Cheng Yi-Fang   Nilsson Dag   Reinholdsson Ingalill   Fransson Bo   Lanbeck Vallén Kerstin   Nyman Lars   Eriksson Catarina   Björck Staffan   Schulman Sam  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1813-1823

Informa Healthcare

Access to resources Recommend Favorite

A phase 1, placebo-controlled, randomised, double-blind (within dose panels) study evaluating the safety, tolerability and pharmacokinetics of intravenous NXY-059 in Japanese subjects

By Watabe Mitsuo   Cheng Yi-Fang   Nilsson Dag   Itoh Yohji   Kumagai Yuji  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1849-1857

Informa Healthcare

Access to resources Recommend Favorite

A novel CRTH2 antagonist: Single‐ and multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ACT‐453859 in healthy subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 787-797

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of the effect of food and gastric pH on the single‐dose pharmacokinetics of cabozantinib in healthy adult subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 91-2700, Iss. 11, 2015-11 ,pp. : 1293-1302

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of the effect of food and gastric pH on the single‐dose pharmacokinetics of cabozantinib in healthy adult subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 11, 2015-11 ,pp. : 1293-1302

John Wiley & Sons Inc

Access to resources Recommend Favorite